Unlocking PD‐1 antibody resistance: The MUC1 DNA vaccine augments CD8<sup>+</sup> T cell infiltration and attenuates tumour suppression
2024 · Scandinavian Journal of Immunology · 2 citations
https://doi.org/10.1111/sji.13356
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
10
Citations
2
h-index
0
i10-index
Xiaoqin Wang is an academic researcher from First Affiliated Hospital of Xi'an Jiaotong University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Immunotherapy and Immune Responses & Cancer-related molecular mechanisms research. The author has an h-index of 2, co-authored 4 publications.
ORCID: 0000-0002-3348-1790Click to start Chat